Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-01 · accession 0000874015-22-000124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-06 | 2022-07-01 | IONS | MUTO FREDERICK T | Dir | M - OptEx | $12.94 | +11.2K | 51.6K | +28% | +$145.6K |
| D | 2022-07-06 | 2022-07-01 | IONS | MUTO FREDERICK T | Dir | M - OptEx | $0.00 | -11.2K | 0 | -100% | $0 |
| DM | 2022-07-06 | 2022-07-01 | IONS | MUTO FREDERICK T | Dir | A - Grant | $0.00 | +17.3K | 15.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | M | A | 11,250 | $12.94 | 51,599 | D | — | — | (F1) Acquired as a result of exercising a stock option that was scheduled to expire on 7/1/2022. |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-07-01 | M | D | 11,250 | $0.00 | 0 | D | $12.94 · 2013-07-02 to 2022-07-01 | 11,250 Common Stock | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-07-01 | A | A | 12,000 | $0.00 | 12,000 | D | $38.06 · 2023-07-01 to 2032-06-30 | 12,000 Common Stock | (F2) Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022. |
| 4 | Derivative | Restricted Stock Unit | 2022-07-01 | A | A | 5,333 | $0.00 | 15,108 | D | $0.00 · — to — | 5,333 Common Stock | (F3) Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. (F4) Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. |